Curaleaf Holdings (CURLF) EBIT Growth (3y) (2022 - 2026)
Curaleaf Holdings (CURLF) EBIT Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 29.31% |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 4.24% |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 0.90% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 1.82% |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -74.25% |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 27.21% |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 35.42% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn | 44.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.02% |
| Mar 31, 2026 | -65.27% |
| Dec 31, 2025 | 28.59% |
| Sep 30, 2025 | -50.14% |
| Jun 30, 2025 | -54.60% |
| Mar 31, 2025 | -40.17% |
| Dec 31, 2024 | -34.84% |
| Sep 30, 2024 | -39.84% |
| Jun 30, 2024 | -47.90% |
| Mar 31, 2024 | -92.94% |
| Dec 31, 2023 | -91.53% |
| Sep 30, 2023 | -2.42% |
| Jun 30, 2023 | -30.00% |
| Mar 31, 2023 | 53.27% |
| Dec 31, 2022 | -123.86% |
| Sep 30, 2022 | 182.45% |